New Psoriasis Drug Gives Hope to Patients who are suffering from this skin conditions, new reports say.
Psoriasis is a chronic immune-mediated systemic disease. It is characterized by lesions on the skin which have the aspect of red patches, plaques and papules that usually swell and itch.
The causes and implications of this disease are not fully understood by scientists. It is well known that psoriasis is not purely a skin disorder. Some causes that produce it are not known, and its effects are not limited solely to the skin area, but can extend to internal organs as well.
Yet, a new study, conducted by a team at the University of Manchester, offers hope to the million of patients who are suffering from it. The team is presently testing the effectiveness of a new drug, called Ixekizumab, and the results are encouraging.
The trials of Ixekizumab show an overall improvement in the medical state of patients with psoriasis. The findings show that about 40 per cent of the patients who participated in the study showed full clearance of their plaques, when the were administered the drug for longer than 12 weeks.
The study involved over 2,500 patients. Half of them were given the experimental drug, while the other half were put on an placebo drug, or on Etanercept, know to be extensively used for psoriasis.
As it was hoped end expected, the group which was given Ixekizumab showed immediate and longer-term improvement while the other group’s improvements were only minimal and unsatisfactory.
How does Ixekizumab work? Well, it goes straight to Interleukin, which is the protein in the skin responsible for carrying signals to cells, and neutralizes its inflammatory effects.
“The visible effects of psoriasis can have a major and life-ruining impact on people’s confidence and self-esteem” University of Manchester’s professor, Chris Griffiths, explained.
Before Ixekizumab drug, the recommended treatments used to treat psoriasis ranged from Ultra-Violet light therapy and topic creams to shampoos and injections. But because each patient is unique, he or she also responded the these treatments in a unique way. This can be a long process of trying new thing that work best on one’s condition, as well as time consuming and frustrating.
Professor Chris Griffits is hopeful regarding the cure of psoriasis and firmly believes that this new treatment will greatly improve the medical condition of millions, or even cure the disease entirely.
He said that up until now their objective was to minimize the symptoms produced by this disease but from this time forward, with the help of the new drug, every patient can hope to attain clear skin without the fear of a relapse.
Image Source: Telegraph